EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 121 filers reported holding EPIZYME INC in Q1 2022. The put-call ratio across all filers is 4.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $63,000 | +26.0% | 43,133 | 0.0% | 0.00% | +50.0% |
| Q1 2022 | $50,000 | -53.7% | 43,133 | 0.0% | 0.00% | -60.0% |
| Q4 2021 | $108,000 | -51.1% | 43,133 | 0.0% | 0.01% | -50.0% |
| Q3 2021 | $221,000 | -38.3% | 43,133 | 0.0% | 0.01% | -41.2% |
| Q2 2021 | $358,000 | -2.2% | 43,133 | +2.7% | 0.02% | -15.0% |
| Q1 2021 | $366,000 | +15.8% | 41,983 | +58.7% | 0.02% | -33.3% |
| Q3 2020 | $316,000 | -23.3% | 26,450 | +3.1% | 0.03% | -23.1% |
| Q2 2020 | $412,000 | – | 25,660 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $79,842,000 | 29.97% |
| Foresite Capital Management III, LLC | 998,278 | $8,695,000 | 7.64% |
| KPCB XIII Associates, LLC | 3,838,166 | $33,430,000 | 6.87% |
| Burrage Capital Management LLC | 564,555 | $4,917,000 | 3.98% |
| Palo Alto Investors LP | 6,856,513 | $59,720,000 | 3.40% |
| MPM BioImpact LLC | 2,331,534 | $20,308,000 | 2.55% |
| Foresite Capital Management II, LLC | 1,000,002 | $8,710,000 | 2.00% |
| Foresite Capital Management I, LLC | 293,759 | $2,559,000 | 1.29% |
| Redmile Group, LLC | 8,824,366 | $76,860,000 | 1.08% |
| Rock Springs Capital Management LP | 2,802,954 | $24,414,000 | 0.53% |